CHICAGO – Health care incubator and accelerator MATTER is partnering with Israel-based Sheba Medical Center to accelerate the commercialization of new technologies for patients in both the U.S. and Israel.
Through the partnership, MATTER startups in the U.S. will have opportunities to pilot their technologies with Sheba Medical Center’s partners. The health system has a highly developed innovation capability and can facilitate pilots for new solutions at a rapid pace.
Sheba Medical Center also supports a number of Israel-based health care technology startups building digital health solutions. Chicago-based MATTER will leverage its network of U.S. entrepreneurs, innovators, health systems, industry partners and experts to help open the door to markets here for Sheba Medical Center-affiliated startups.
“MATTER is the perfect platform for Israeli health care companies to enter the U.S. market,” said Steven Collens, CEO of MATTER, in a statement. “Israel has developed one of the most productive startup ecosystems in the world, and we look forward to engaging with the Israeli startup community.”
Dr. Eyal Zimlichman, deputy director of Sheba Medical Center, said the two organizations share the same vision for innovation and improved universal health care.
“I believe the collaboration between the two organizations will be instrumental in pushing our vision forward,” he said.
The agreement between the two organizations was signed during Collens’ recent trip to Israel with Chicago Mayor Rahm Emanuel and World Business Chicago. The delegation was formed to promote investment and innovation in Chicago.
“I look forward to seeing what this partnership between two innovative organizations produces to benefit people throughout the world,” Emanuel said.
MATTER works with 200 health care technology startups and partners with 11 hospitals and health systems, five universities and more than 40 industry-leading companies to accelerate the development of health care technologies.
Sheba Medical Center is a university-affiliated tertiary referral hospital that serves as Israel’s national medical center in many fields, and is also a major medical-scientific research center that collaborates internationally with the biotech and pharmaceutical industries to develop new drugs, treatments and technologies, and a global center for medical education.